Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor
Open Access
- 14 June 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 1 (5) , 983-993
Abstract
The coronavirus (CoV) disease 2019 (COVID-19) is expected to become endemic in the coming years, meaning that the worldwide society shall be prepared to routinely manage the highly contagious respiratory SARS-CoV-2. A rapid and early diagnosis of the SARS-CoV-2 infection is crucial for controlling the spread of the disease, interrupting the transmission chain, and providing timely medical attention to patients. We introduce an innovative nanophotonic biosensor for the quantitative detection of viral particles in less than 20 minutes total assay time. The nanosensor, based on the bimodal waveguide (BiMW) interferometric technology, has been functionalized with novel bioengineered nanobodies (Nb) targeting the SARS-CoV-2 receptor-binding domain (RBD). Our approach relies on the direct capture of the viral particles, and the optimized methodology allows the detection of the SARS-CoV-2 virus with outstanding sensitivity, below 200 TCID50 per mL, being able to provide accurate viral load determination within a broad dynamic range (102–106 TCID50 per mL). Both the nanobodies and the sensor nanotechnology can be produced at a large scale with highly-efficient cost-effective procedures, and they are being integrated into a user-friendly point-of-care device for multiplexed and decentralized operation. The implementation of this unique biosensor in primary care assistance, hospitals, pharmacies, or private laboratories could greatly aid in the relief and descongestion of the sanitary systems and the clinical and social management of COVID-19.Keywords
Funding Information
- Consejo Superior de Investigaciones Científicas (CSIC-COV19-082/104, PIE-RD-COVID 19 (No 202020E079), SGL 2103051, PTI Salud Global)
- European Commission (H2020-SC1-PHE-Coronavirus-2020, 101003544)
- Centres de Recerca de Catalunya
- Agencia Estatal de Investigación (SEV-2017-0706)
- Ministero della Salute (SEV-2017-0706)
This publication has 37 references indexed in Scilit:
- Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor TherapeuticsFrontiers in Immunology, 2017
- Analysis of alternative splicing events for cancer diagnosis using a multiplexing nanophotonic biosensorScientific Reports, 2017
- Label-free bimodal waveguide immunosensor for rapid diagnosis of bacterial infections in cirrhotic patientsBiosensors and Bioelectronics, 2016
- Nanobodies as therapeutics: big opportunities for small antibodiesDrug Discovery Today, 2016
- Direct and Label-Free Quantification of Micro-RNA-181a at Attomolar Level in Complex Media Using a Nanophotonic BiosensorACS Sensors, 2016
- Last Advances in Silicon-Based Optical BiosensorsSensors, 2016
- Selection of Single Domain Antibodies from Immune Libraries Displayed on the Surface of E. coli Cells with Two β-Domains of Opposite TopologiesPLOS ONE, 2013
- Nanobodies: Natural Single-Domain AntibodiesAnnual Review of Biochemistry, 2013
- Integrated Bimodal Waveguide Interferometric Biosensor for Label-Free AnalysisJournal of Lightwave Technology, 2011
- A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12American Journal of Epidemiology, 1938